About
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers biosimilars, active pharmaceutical ingredients, branded and trade generics, complex generics, and consumer wellness products in therapeutic areas comprising anti Β infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology, central nervous system, anti-diabetic, iron deficiency, pain management, and urology, as well as vitamins, minerals, and nutrients. It also provides cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. Alkem Laboratories Limited was incorporated in 1973 and is based in Mumbai, India.
Key Metrics
as of Sep 2026Market Cap62,054 Cr
P/E27.30
Div Yield1.02 %
Book ValueβΉ1,156.00
52w HighβΉ5,934.00
52w LowβΉ5,075.00
Face ValueβΉ2.00
Quarterly Results
Rs. Crores Β· hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,668.00 | 2,258.00 | 2,491.00 | 2,542.00 | 2,372.00 | 2,045.00 | 2,287.00 | 2,355.00 | 2,127.00 | 2,365.00 | 2,009.00 | 2,635.00 | 2,253.00 |
| Expenses | 1,931.00 | 1,914.00 | 1,802.00 | 1,771.00 | 1,752.00 | 1,748.00 | 1,629.00 | 1,714.00 | 1,566.00 | 1,958.00 | 1,517.00 | 1,980.00 | 1,919.00 |
| Operating Profit | 737.00 | 344.00 | 689.00 | 771.00 | 620.00 | 297.00 | 658.00 | 640.00 | 561.00 | 408.00 | 492.00 | 655.00 | 334.00 |
| OPM % | 28.00 | 15.00 | 28.00 | 30.00 | 26.00 | 15.00 | 29.00 | 27.00 | 26.00 | 17.00 | 25.00 | 25.00 | 15.00 |
| Other Income | 137.00 | 86.00 | 93.00 | 164.00 | 165.00 | 163.00 | 216.00 | 176.00 | 144.00 | 71.00 | 93.00 | 62.00 | 65.00 |
| Depreciation | 57.00 | 78.00 | 61.00 | 59.00 | 59.00 | 92.00 | 68.00 | 61.00 | 63.00 | 69.00 | 57.00 | 59.00 | 58.00 |
| Interest | 18.00 | 16.00 | 16.00 | 13.00 | 13.00 | 17.00 | 21.00 | 17.00 | 21.00 | 21.00 | 21.00 | 19.00 | 21.00 |
| Profit before tax | 798.00 | 336.00 | 706.00 | 864.00 | 714.00 | 351.00 | 785.00 | 738.00 | 621.00 | 389.00 | 508.00 | 639.00 | 319.00 |
| Tax % | 29.00 | 35.00 | 12.00 | 9.00 | 8.00 | 21.00 | 8.00 | 5.00 | 6.00 | 16.00 | 1.00 | -1.00 | 15.00 |
| Net Profit | 570.00 | 217.00 | 622.00 | 787.00 | 656.00 | 277.00 | 723.00 | 698.00 | 583.00 | 325.00 | 504.00 | 647.00 | 271.00 |
| EPS in Rs | 47.67 | 18.15 | 52.03 | 65.80 | 54.88 | 23.16 | 60.48 | 58.34 | 48.78 | 27.18 | 42.17 | 54.07 | 22.70 |
Profit & Loss
Annual Β· Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,664.00 | 8,813.00 | 7,964.00 | 9,055.00 | 8,830.00 | 7,220.00 | 6,677.00 | 5,714.00 | 5,281.00 | 4,548.00 | 3,911.00 | 3,072.00 |
| Expenses | 7,239.00 | 6,657.00 | 6,290.00 | 7,665.00 | 7,018.00 | 5,268.00 | 5,209.00 | 4,667.00 | 4,308.00 | 3,668.00 | 3,180.00 | 2,722.00 |
| Operating Profit | 2,425.00 | 2,156.00 | 1,674.00 | 1,389.00 | 1,812.00 | 1,951.00 | 1,468.00 | 1,048.00 | 973.00 | 880.00 | 731.00 | 350.00 |
| OPM % | 25.00 | 24.00 | 21.00 | 15.00 | 21.00 | 27.00 | 22.00 | 18.00 | 18.00 | 19.00 | 19.00 | 11.00 |
| Other Income | 509.00 | 698.00 | 426.00 | 254.00 | 199.00 | 175.00 | 96.00 | 66.00 | 101.00 | 115.00 | 240.00 | 177.00 |
| Interest | 57.00 | 76.00 | 80.00 | 86.00 | 38.00 | 43.00 | 39.00 | 28.00 | 32.00 | 24.00 | 59.00 | 73.00 |
| Depreciation | 257.00 | 284.00 | 239.00 | 230.00 | 219.00 | 199.00 | 187.00 | 141.00 | 108.00 | 76.00 | 74.00 | 60.00 |
| Profit before tax | 2,620.00 | 2,495.00 | 1,781.00 | 1,327.00 | 1,753.00 | 1,884.00 | 1,338.00 | 944.00 | 934.00 | 894.00 | 839.00 | 395.00 |
| Tax % | 13.00 | 9.00 | 2.00 | 15.00 | 12.00 | 11.00 | 6.00 | 15.00 | 23.00 | 1.00 | 17.00 | 7.00 |
| Net Profit | 2,282.00 | 2,281.00 | 1,747.00 | 1,134.00 | 1,541.00 | 1,685.00 | 1,264.00 | 800.00 | 716.00 | 883.00 | 700.00 | 368.00 |
| EPS in Rs | 190.87 | 190.77 | 146.13 | 94.88 | 128.90 | 140.93 | 105.75 | 66.90 | 59.87 | 73.86 | 58.56 | 30.75 |
| Dividend Payout % | 28.00 | 24.00 | 27.00 | 53.00 | 26.00 | 21.00 | 24.00 | 24.00 | 22.00 | 20.00 | 22.00 | 13.00 |
Balance Sheet
Annual Β· Rs. Crores β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
| Reserves | 13,975.00 | 12,298.00 | 10,531.00 | 9,326.00 | 8,720.00 | 7,602.00 | 6,257.00 | 5,441.00 | 4,861.00 | 4,369.00 | 3,576.00 | 3,077.00 |
| Borrowings | 611.00 | 439.00 | 1,005.00 | 1,182.00 | 2,294.00 | 1,384.00 | 1,209.00 | 503.00 | 548.00 | 368.00 | 380.00 | 1,103.00 |
| Other Liabilities | 2,651.00 | 2,835.00 | 2,478.00 | 2,200.00 | 2,132.00 | 1,763.00 | 1,616.00 | 1,324.00 | 1,381.00 | 1,137.00 | 843.00 | 657.00 |
| Total Liabilities | 17,261.00 | 15,596.00 | 14,038.00 | 12,731.00 | 13,169.00 | 10,773.00 | 9,106.00 | 7,292.00 | 6,814.00 | 5,898.00 | 4,822.00 | 4,861.00 |
| Fixed Assets | 1,550.00 | 1,591.00 | 1,782.00 | 1,825.00 | 1,882.00 | 1,758.00 | 1,837.00 | 1,606.00 | 1,471.00 | 1,126.00 | 875.00 | 870.00 |
| CWIP | 123.00 | 76.00 | 91.00 | 229.00 | 232.00 | 323.00 | 314.00 | 382.00 | 299.00 | 218.00 | 147.00 | 96.00 |
| Investments | 5,552.00 | 4,407.00 | 2,829.00 | 3,006.00 | 2,529.00 | 2,152.00 | 1,956.00 | 1,696.00 | 1,544.00 | 1,518.00 | 1,158.00 | 1,071.00 |
| Other Assets | 10,037.00 | 9,521.00 | 9,336.00 | 7,672.00 | 8,526.00 | 6,539.00 | 4,999.00 | 3,609.00 | 3,500.00 | 3,037.00 | 2,644.00 | 2,824.00 |
| Total Assets | 17,261.00 | 15,596.00 | 14,038.00 | 12,731.00 | 13,169.00 | 10,773.00 | 9,106.00 | 7,292.00 | 6,814.00 | 5,898.00 | 4,822.00 | 4,861.00 |
Cash Flows
Annual Β· Rs. Crores β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1,969.00 | 2,189.00 | 1,687.00 | 1,437.00 | 1,299.00 | 1,324.00 | 682.00 | 745.00 | 318.00 | 499.00 | 630.00 | 242.00 |
| Cash from Investing Activity | -1,461.00 | -1,007.00 | -866.00 | 197.00 | -1,669.00 | -1,121.00 | -995.00 | -313.00 | -273.00 | -362.00 | 311.00 | -260.00 |
| Cash from Financing Activity | -673.00 | -1,037.00 | -959.00 | -1,711.00 | 437.00 | -209.00 | 173.00 | -276.00 | -60.00 | -125.00 | -958.00 | 26.00 |
| Net Cash Flow | -165.00 | 145.00 | -138.00 | -77.00 | 67.00 | -5.00 | -141.00 | 156.00 | -15.00 | 13.00 | -17.00 | 8.00 |
| Free Cash Flow | 1,822.00 | 2,003.00 | 1,586.00 | 1,298.00 | 1,065.00 | 1,230.00 | 415.00 | 392.00 | -175.00 | 47.00 | 463.00 | 111.00 |
| CFO/OP % | 101.00 | 120.00 | 122.00 | 120.00 | 90.00 | 84.00 | 62.00 | 91.00 | 51.00 | 80.00 | 106.00 | 99.00 |
Ratios
Annual Β· Days / % β latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 59.00 | 65.00 | 80.00 | 71.00 | 73.00 | 79.00 | 85.00 | 62.00 | 60.00 | 51.00 | 45.00 | 45.00 |
| Inventory Days | 212.00 | 196.00 | 257.00 | 164.00 | 202.00 | 207.00 | 156.00 | 159.00 | 180.00 | 175.00 | 139.00 | 143.00 |
| Days Payable | 192.00 | 188.00 | 219.00 | 103.00 | 114.00 | 131.00 | 116.00 | 121.00 | 144.00 | 139.00 | 110.00 | 90.00 |
| Cash Conversion Cycle | 79.00 | 72.00 | 119.00 | 133.00 | 162.00 | 155.00 | 125.00 | 100.00 | 97.00 | 86.00 | 74.00 | 97.00 |
| Working Capital Days | 123.00 | 128.00 | 171.00 | 50.00 | 13.00 | 45.00 | 39.00 | 51.00 | 43.00 | 29.00 | 12.00 | -62.00 |
| ROCE % | 20.00 | 20.00 | 16.00 | 13.00 | 18.00 | 23.00 | 20.00 | 17.00 | 19.00 | 21.00 | 22.00 | 11.00 |
Corporate Actions
22 records| Action | Ex Date | Record Date | Ratio | Amount (βΉ) | Notes |
|---|---|---|---|---|---|
| Dividend | 07 Aug 2026 | 07 Aug 2026 | β | 10.00 | |
| Dividend | 20 Feb 2026 | 20 Feb 2026 | β | 43.00 | |
| Dividend | 08 Aug 2025 | 08 Aug 2025 | β | 8.00 | |
| Dividend | 14 Feb 2025 | 14 Feb 2025 | β | 37.00 | |
| Dividend | 09 Aug 2024 | 10 Aug 2024 | β | 5.00 | |
| Dividend | 16 Feb 2024 | 17 Feb 2024 | β | 35.00 | |
| Dividend | 10 Aug 2023 | 10 Aug 2023 | β | 10.00 | |
| Dividend | 17 Feb 2023 | 18 Feb 2023 | β | 25.00 | NSE/BSE dividend mismatch: BSE/NSE=15.0; BSE/NSE=25.0 |
| Dividend | 17 Feb 2023 | 18 Feb 2023 | β | 15.00 | NSE/BSE dividend mismatch: BSE/NSE=15.0; BSE/NSE=25.0 |
| Dividend | 08 Aug 2022 | 10 Aug 2022 | β | 4.00 | |
| Dividend | 10 Feb 2022 | 12 Feb 2022 | β | 30.00 | |
| Dividend | 09 Aug 2021 | 10 Aug 2021 | β | 5.00 | |
| Dividend | 11 Feb 2021 | 13 Feb 2021 | β | 25.00 | |
| Dividend | 10 Aug 2020 | 11 Aug 2020 | β | 3.00 | |
| Dividend | 13 Feb 2020 | 15 Feb 2020 | β | 22.00 | |
| Dividend | 19 Aug 2019 | 20 Aug 2019 | β | 8.00 | |
| Dividend | 15 Feb 2019 | 18 Feb 2019 | β | 8.00 | |
| Dividend | 23 Aug 2018 | 24 Aug 2018 | β | 7.00 | |
| Dividend | 16 Feb 2018 | 20 Feb 2018 | β | 6.00 | |
| Dividend | 31 Aug 2017 | 01 Sep 2017 | β | 9.00 | |
| Dividend | 23 Nov 2016 | 24 Nov 2016 | β | 6.00 | |
| Dividend | 18 Mar 2016 | 21 Mar 2016 | β | 9.70 |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results β Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update8 Jul from crisil
-
Rating update24 Feb from crisil
-
Rating update6 Feb from fitch
-
Rating update5 Jan from care
-
Rating update15 Sep 2025 from crisil
-
Rating update7 Feb 2025 from fitch
Conference Calls
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript